Clinical Trials Browser

Terminated × Prostatic Neoplasms × TroVax × Clear all

NCT01194960 2020-10-19

TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)

Phase 2 Terminated

Prostatic Hyperplasia, Prostatic Neoplasms

NCT00521274 2016-03-17

Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer

Phase 2 Terminated

Prostatic Neoplasms